A detailed history of Slagle Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Slagle Financial, LLC holds 6,744 shares of AMGN stock, worth $2.14 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
6,744
Previous 6,250 7.9%
Holding current value
$2.14 Million
Previous $1.95 Billion 11.29%
% of portfolio
0.96%
Previous 1.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$309.38 - $337.38 $152,833 - $166,665
494 Added 7.9%
6,744 $2.17 Billion
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $192,070 - $233,415
731 Added 13.25%
6,250 $1.95 Billion
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $842,369 - $1.02 Million
3,133 Added 131.31%
5,519 $1.57 Billion
Q4 2023

Mar 05, 2024

BUY
$255.7 - $288.46 $307,351 - $346,728
1,202 Added 101.52%
2,386 $344 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $258,881 - $321,408
1,184 New
1,184 $318 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Slagle Financial, LLC Portfolio

Follow Slagle Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slagle Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slagle Financial, LLC with notifications on news.